An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system
- 1 May 2001
- journal article
- Published by Wolters Kluwer Health in Pain
- Vol. 92 (1) , 101-106
- https://doi.org/10.1016/s0304-3959(00)00475-9
Abstract
Calcitonin gene related peptide (CGRP) released from the C-fibers projecting from the trigeminal ganglion to the meninges has been suggested to play a crucial role in the pathophysiology of headache, particularly migraine. In humans it has been shown that CGRP is released during migraine-attKeywords
This publication has 26 references indexed in Scilit:
- Pharmacological aspects of experimental headache models in relation to acute antimigraine therapyEuropean Journal of Pharmacology, 1999
- Neuropeptides in headacheEuropean Journal of Neurology, 1998
- Modification of vasoconstrictor responses in cerebral blood vessels by lesioning of the trigeminal nerve: Possible involvement of CGRPCephalalgia, 1995
- Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulationNeuroscience, 1992
- Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglionNeuropharmacology, 1991
- Trigeminal sensory fiber stimulation induces morphological changes reflecting secretion in rat dura mater mast cellsNeuroscience, 1991
- The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura materBritish Journal of Pharmacology, 1990
- Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura materEuropean Journal of Pharmacology, 1989
- Peptide‐containing nerve fibers in human cerebral arteries: Immunocytochemistry, radioimmunoassay and in vitro pharmacologyAnnals of Neurology, 1987
- Calcitonin gene-related peptide is a potent vasodilatorNature, 1985